Fintel reports that on May 14, 2026, Wedbush upgraded their outlook for STAAR Surgical (NasdaqGM:STAA) from Neutral to Outperform.
Analyst Price Forecast Suggests 32.72% Downside
As of May 14, 2026, the average one-year price target for STAAR Surgical is $21.53/share. The forecasts range from a low of $16.16 to a high of $28.35. The average price target represents a decrease of 32.72% from its latest reported closing price of $32.00 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for STAAR Surgical is 584MM, an increase of 101.22%. The projected annual non-GAAP EPS is 3.77.
What is the Fund Sentiment?
There are 209 funds or institutions reporting positions in STAAR Surgical. This is an decrease of 159 owner(s) or 43.21% in the last quarter. Average portfolio weight of all funds dedicated to STAA is 0.52%, an increase of 81.70%. Total shares owned by institutions decreased in the last three months by 10.25% to 54,085K shares. 
The put/call ratio of STAA is 0.48, indicating a bullish outlook.
What are Other Shareholders Doing?
Broadwood Capital holds 15,019K shares representing 30.33% ownership of the company. In its prior filing, the firm reported owning 13,519K shares , representing an increase of 9.99%. The firm decreased its portfolio allocation in STAA by 6.81% over the last quarter.
Yunqi Capital holds 3,257K shares representing 6.58% ownership of the company. In its prior filing, the firm reported owning 2,507K shares , representing an increase of 23.03%. The firm increased its portfolio allocation in STAA by 42.79% over the last quarter.
Vanguard Portfolio Management holds 2,124K shares representing 4.29% ownership of the company.
Goldman Sachs Group holds 2,077K shares representing 4.19% ownership of the company. In its prior filing, the firm reported owning 976K shares , representing an increase of 52.99%. The firm increased its portfolio allocation in STAA by 84.21% over the last quarter.
Vanguard Capital Management holds 1,691K shares representing 3.41% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
